Betahistine is a pharmaceutical compound primarily used to treat vertigo and balance disorders, such as Ménière’s disease. It works by improving blood flow in the inner ear, which helps reduce the buildup of pressure that causes dizziness and hearing loss. Chemically, betahistine is a structural analog of histamine and acts as a weak histamine H1 receptor agonist and a strong H3 receptor antagonist. The drug was first synthesized and introduced in the 1960s, with initial research focusing on its effects on the vestibular system. Over the decades, betahistine gained acceptance worldwide due to its efficacy in managing symptoms related to inner ear disorders. It is administered orally, typically in tablet form, and is considered safe with relatively mild side effects. Betahistine’s mechanism of action involves vasodilation in the inner ear and modulation of neurotransmitter release, which contributes to its symptom-relieving effects. Research continues into its broader applications, including potential benefits in cognitive disorders linked to vestibular dysfunction. Today, it remains one of the most commonly prescribed treatments for vertigo and balance-related ailments globally.
BRAND NAMES
Serc (one of the most widely known brands)
Betaserc
Vertin (commonly used in India)
Betahist
Vergo
Betavert
MECHANISM OF ACTION
Betahistine works as a histamine analogue by stimulating H1 receptors and blocking H3 receptors, which improves blood flow in the inner ear. This reduces fluid pressure and helps restore balance, thereby relieving symptoms of vertigo and dizziness.
PHARMACOKINETICS
Absorption
Oral Administration – Betahistine is taken by mouth, usually as a tablet.
Gastrointestinal Absorption – Rapidly absorbed through the stomach and small intestine.
Peak Plasma Levels – Reached within approximately 1 hour after ingestion.
Distribution
Betahistine, plasma protein binding is very low (less than 5%), meaning it is widely distributed in body tissues rather than being bound in the blood.
Metabolism
Betahistine is rapidly and extensively metabolized in the liver, primarily into 2-pyridylacetic acid, which is its main inactive metabolite. This process occurs quickly after absorption, resulting in very low levels of unchanged drug in the bloodstream.
Excretion
Betahistine is primarily excreted through the kidneys in the urine, mainly as its inactive metabolite, 2-pyridylacetic acid. Most of the administered dose is eliminated within 24 hours.
PHARMACODYNAMICS
Betahistine works by stimulating H1 receptors and blocking H3 receptors, which improves blood flow in the inner ear and reduces fluid pressure. This helps restore balance and relieves vertigo and dizziness.
ADMINISTRATION
Betahistine is given orally, usually as tablets, and should be taken with or after food to minimize stomach upset. The dosage and frequency are tailored to the patient’s condition and response.
DOSAGE AND STRENGTH
Strengths: Commonly available in 8 mg, 16 mg, and 24 mg tablets
Adults: Typically 16–24 mg orally 2–3 times daily, depending on severity of vertigo
Elderly: Start with lower doses and adjust as tolerated
Children: Use only if specifically prescribed; pediatric dosing varies
FOOD INTERACTIONS
Betahistine has minimal food interactions. Taking it with or after meals is recommended to reduce stomach irritation, but food does not significantly affect its absorption or effectiveness.
DRUG INTERACTIONS
Antihistamines (H1 blockers) – can reduce betahistine’s effectiveness by blocking its action.
Histamine H2 receptor antagonists (e.g., ranitidine) – may slightly decrease its activity.
Other vestibular suppressants (e.g., benzodiazepines, anticholinergics) – may alter overall vertigo management.
CONTRAINDICATIONS
Hypersensitivity to betahistine or any of its components
Pheochromocytoma (risk of hypertensive crisis due to increased histamine release)
Active peptic ulcer or severe gastrointestinal bleeding
Severe cardiovascular disease in some cases (use with caution)
SIDE EFFECTS
Common Side Effects of Betahistine:
Headache
Nausea or vomiting
Stomach upset or dyspepsia
Mild allergic reactions (rash, itching)
TOXICITY
Betahistine has a low toxicity profile. In cases of overdose, patients may experience headache, nausea, flushing, or low blood pressure, and treatment is usually supportive and symptomatic.
